Skip to main content
Erschienen in: International Cancer Conference Journal 4/2019

15.06.2019 | Case report

Testicular rhabdomyosarcoma after chemotherapy for metastatic germ cell tumors

verfasst von: Ryunosuke Nakagawa, Shuhei Aoyama, Satoko Urata, Mitsuo Ofude, Tohru Miyagi, Takao Nakashima, Yurie Okayama, Kazuyoshi Katayanagi

Erschienen in: International Cancer Conference Journal | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

A 36-year-old male was referred to our hospital with left scrotal swelling. Computed tomography revealed a massive tumor in his left scrotum. The tumor extended along the gonadal vein extraperitoneally forming a massive tumor. Pathological examination showed a mixed-type germ cell tumor. Despite several chemotherapeutic treatments, the tumor continued to grow, and the patient died 28 months later after his first presentation at our institution. Autopsy revealed that the tumor comprised rhabdomyosarcoma and mature teratoma. We could not find useful tumor markers to facilitate the diagnosis of rhabdomyosarcoma. However, we recommend rebiopsy or palliative operation as options for re-diagnosis in case of resistant germ cell tumor. Here, we present a case of testicular tumor that exhibited different pathological examination results before and after treatment.
Literatur
1.
Zurück zum Zitat Motzer Robert J, Amsterdam Alison, Prieto Victor et al (1998) Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133–138CrossRefPubMed Motzer Robert J, Amsterdam Alison, Prieto Victor et al (1998) Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133–138CrossRefPubMed
2.
3.
4.
Zurück zum Zitat Logothetis CJ, Samuels ML, Trindade A et al (1982) The growing teratoma syndrome. Cancer 50:1629–1635CrossRefPubMed Logothetis CJ, Samuels ML, Trindade A et al (1982) The growing teratoma syndrome. Cancer 50:1629–1635CrossRefPubMed
5.
Zurück zum Zitat Comiter CV, Kibel AS, Richie JP et al (1998) Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 159:859–863CrossRefPubMed Comiter CV, Kibel AS, Richie JP et al (1998) Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol 159:859–863CrossRefPubMed
6.
Zurück zum Zitat Giannatempo P, Pond GR, Sonpavde G et al (2016) Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation: an international collaboration. J Urol 96:95–100CrossRef Giannatempo P, Pond GR, Sonpavde G et al (2016) Treatment and clinical outcomes of patients with teratoma with somatic-type malignant transformation: an international collaboration. J Urol 96:95–100CrossRef
7.
Zurück zum Zitat Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26:2384–2389CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Meza JL, Anderson J, Pappo AS et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol 24:3844–3851CrossRefPubMed Meza JL, Anderson J, Pappo AS et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. J Clin Oncol 24:3844–3851CrossRefPubMed
9.
Zurück zum Zitat Breneman JC, Lyden E, Pappo AS et al (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 1:78–84CrossRef Breneman JC, Lyden E, Pappo AS et al (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 1:78–84CrossRef
10.
Zurück zum Zitat Spiess PE, Kassouf W, Brown GA et al (2007) Surgical management of growing teratoma syndrome. The J Urol 177:1330–1334CrossRefPubMed Spiess PE, Kassouf W, Brown GA et al (2007) Surgical management of growing teratoma syndrome. The J Urol 177:1330–1334CrossRefPubMed
11.
Zurück zum Zitat Mitsuru Miyachi, Kunihiko Tsuchiya, Hideki Yoshida et al (2010) Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun 10:89–93 Mitsuru Miyachi, Kunihiko Tsuchiya, Hideki Yoshida et al (2010) Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun 10:89–93
12.
Zurück zum Zitat Masahiro M, Ikuyoshi H, Shigeyuki Y (2000) CA19-9 producing testicular tumor: a case report. Acta Urol Jpn 46:45–47 Masahiro M, Ikuyoshi H, Shigeyuki Y (2000) CA19-9 producing testicular tumor: a case report. Acta Urol Jpn 46:45–47
13.
Zurück zum Zitat Tsuruta T, Ogawa A, Ikado S et al (1997) CA19-9: a possible serum marker for embryonal carcinoma. Urol Int 58:20–24CrossRefPubMed Tsuruta T, Ogawa A, Ikado S et al (1997) CA19-9: a possible serum marker for embryonal carcinoma. Urol Int 58:20–24CrossRefPubMed
14.
Zurück zum Zitat Indraneel B, Vinay T, Sher S et al (2016) Role of urinary and serum carbohydrate antigen 19–9 as a biomarker in diagnosis of adult giant hydronephrosis. J Clin Diagn Res 10:8–11 Indraneel B, Vinay T, Sher S et al (2016) Role of urinary and serum carbohydrate antigen 19–9 as a biomarker in diagnosis of adult giant hydronephrosis. J Clin Diagn Res 10:8–11
15.
Zurück zum Zitat Meyer A, Kausch I, Kruger S et al (2004) Elevation of CA19-9 in giant hydronephrosis induced by a renal calculus. Urology 63:381–382CrossRefPubMed Meyer A, Kausch I, Kruger S et al (2004) Elevation of CA19-9 in giant hydronephrosis induced by a renal calculus. Urology 63:381–382CrossRefPubMed
16.
Zurück zum Zitat Korfel A, Fischer L, Foss H-D et al (2001) Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature. Bone Marrow Transplant 28:787–789CrossRefPubMed Korfel A, Fischer L, Foss H-D et al (2001) Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature. Bone Marrow Transplant 28:787–789CrossRefPubMed
Metadaten
Titel
Testicular rhabdomyosarcoma after chemotherapy for metastatic germ cell tumors
verfasst von
Ryunosuke Nakagawa
Shuhei Aoyama
Satoko Urata
Mitsuo Ofude
Tohru Miyagi
Takao Nakashima
Yurie Okayama
Kazuyoshi Katayanagi
Publikationsdatum
15.06.2019
Verlag
Springer Singapore
Erschienen in
International Cancer Conference Journal / Ausgabe 4/2019
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-019-00378-2

Weitere Artikel der Ausgabe 4/2019

International Cancer Conference Journal 4/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.